Luwen Mu
- Hepatology top 2%
- Oncology
- Surgery
- Pathology and Forensic Medicine top 10%
- Pulmonary and Respiratory Medicine
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (13 papers)Cancer Immunotherapy and Biomarkers (5 papers)Liver Disease Diagnosis and Treatment (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Luwen Mu
23 papers receiving 648 citations
Peers
Comparison fields: 5 of 57
- Hepatology 402
- Oncology 228
- Surgery 168
- Pathology and Forensic Medicine 146
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Luwen Mu
This map shows the geographic impact of Luwen Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwen Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwen Mu more than expected).
Fields of papers citing papers by Luwen Mu
This network shows the impact of papers produced by Luwen Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwen Mu. The network helps show where Luwen Mu may publish in the future.
Co-authorship network of co-authors of Luwen Mu
This figure shows the co-authorship network connecting the top 25 collaborators of Luwen Mu. A scholar is included among the top collaborators of Luwen Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwen Mu. Luwen Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 21 | |
| 7 | 5 | |
| 8 | 47 | |
| 9 | 128 | |
| 10 | 15 | |
| 11 | 5 | |
| 12 | 4 | |
| 13 | 23 | |
| 14 | 4 | |
| 15 | 12 | |
| 16 | 202 | |
| 17 | 30 | |
| 18 | 26 | |
| 19 | 49 | |
| 20 | 29 |
About Luwen Mu
Luwen Mu is a scholar working on Hepatology, Microbiology and Biological Psychiatry, having authored 23 papers that have together received 652 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Hepatology (402 citations), Oncology (228 citations) and Pathology and Forensic Medicine (146 citations). Luwen Mu has collaborated with scholars based in China and United States. Frequent co-authors include Ning Lyu, Ming Zhao, Qiankun Xie, Shaolong Li, Haijing Deng, Yanan Kong, Jibin Li, Youen Lin, Peihong Wu and Tao Pan. Their work appears in journals such as Journal of Hepatology, Annals of Oncology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.